Becker's Healthcare June 3, 2024
Houston Methodist is using an FDA-cleared wearable to monitor tens of thousands of patients, which has led to improved patient outcomes and safety, Sarah Pletcher, MD, the system’s executive medical director of strategic innovation, told Becker’s.
The BioIntelliSense BioButton is being used across 2,653 non-ICU beds at Houston Methodist’s eight hospitals. Given to patients upon admission, it is monitored by the hospital’s centralized command center.
This device employs AI-driven analytics to detect changes in vital sign trends, allowing the monitoring team to coordinate care with bedside staff across various medical-surgical units and specialty areas, including oncology, cardiology, neurology, transplantation and maternal health.
With the BioButton, Houston Methodist has seen an increase in patient satisfaction.
“The BioButton enhances the...
Today's Sponsors
Today's Sponsor